24-hour QT variability in heart failure.
暂无分享,去创建一个
Luigi Tavazzi | L. Tavazzi | M. L. La Rovere | C. Olsen | M. Haigney | Craig P. Dobson | Maria Teresa La Rovere | Craig P. Dobson | Cara Olsen | Marino Berardinangeli | Marco Veniani | Paolo Midi | Mark Haigney | P. Midi | M. Veniani | Marino Berardinangeli
[1] J. Muller,et al. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. The CPI Investigators. , 1995, Circulation.
[2] S. Willich,et al. Circadian variation in the frequency of sudden cardiac death. , 1987, Circulation.
[3] E. Prystowsky,et al. Prolongation of the Q-T interval in man during sleep. , 1983, The American journal of cardiology.
[4] D. Roden,et al. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.
[5] A. Moss,et al. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. , 2004, Journal of the American College of Cardiology.
[6] Vikram K Yeragani,et al. Increased beat-to-beat QT variability in patients with congestive cardiac failure. , 2005, Indian heart journal.
[7] H. Calkins,et al. Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. , 1997, Circulation.
[8] Jørgen K. Kanters,et al. QT dynamics in risk stratification after myocardial infarction. , 2005, Heart rhythm.
[9] L. Tavazzi,et al. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n‐3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure , 2004, European journal of heart failure.